Table 1.
Disease | Species | Symptoms | Literature | |
---|---|---|---|---|
Neuropathological | Behavioral | |||
Alzheimer’s disease | Human | Oxidative stress Neuroinflammation Disruption of neuronal cytoskeleton Impaired neuronal transport Synaptic dysfunction Senile plaques and Aβ aggregates NFTs, hyperphosphorylated tau accumulations Brain atrophy Neuronal loss |
Loss of cognition and recognition Disorientation Apathy Poor judgment Intensified aggression or passiveness Changes in interest in food Poor judgment Difficulties in speaking, swallowing and walking Worsening memory |
[18,19,21,22,23,24,25,56] |
Alzheimer’s-like disease | Domestic cat | Aβ oligomers aggregates in cats aged 8 and more Senile plaques in cats aged 10 and more NFTs only in the presence of Aβ Neuronal loss Neuronal degradation |
Spatial disorientation or confusion Altered social relationships Intensified aggression or passiveness Changes in daily schedule and wake-sleep pattern Changes in interest in food Decreased grooming Inappropriate vocalization |
[66,67,68,69,70,71] |
Camel | Diffuse-type senile plaques in the cerebral cortex | No data | [91] | |
Elephant | Aβ cerebral deposition | [90] | ||
Cattle | Aβ cerebral deposition | [89] | ||
Horse | Tau accumulations Axonal transport deficiencies Diffuse Aβ plaques |
[87] | ||
Sea lion | CSF markers which are found in AD | [92] | ||
Dolphin | Amyloid and tau pathology in the brain | [92] | ||
Gorilla | Diffuse-type senile plaques Vascular amyloid |
[95,97] | ||
Baboon | Diffuse-type senile plaques Vascular amyloid Hyperphosphorylated tau in the oldest individuals |
[93,98] | ||
Squirrel monkey | Senile plaques Diffuse-type senile plaques Vascular amyloid |
[94] | ||
Chimpanzee | Diffuse-type senile plaques Vascular amyloid |
[96] | ||
Macaque | Senile plaques Vascular amyloid |
[95] | ||
Sheep | NFTs Aβ cerebral deposition |
[88] | ||
Cheetah | Amyloid plaques NFTs |
[20] | ||
Bears | Amyloid plaques NFTs |
[20] | ||
Goats | NFTs | [20] | ||
Canine Cognitive Dysfunction (CCD) | Dog | Cortical atrophy Dysfunction in the neurotransmitter systems Increased oxidative damage Extracellular deposition of diffuse Aβ Neuronal loss Decreased neurogenesis Tau abnormalities, but not NFTs Ventricular enlargement Oligomers of Aβ in the CSF |
Loss of cognition and recognition Loss of house training Disorientation Changes in their sleep-wake cycle |
[74,75,76,77,78,79,80,81,82,84,85,86] |